Case Over Skelaxin 'Sham' IP Suits Heads To State Court
A Tennessee federal judge ruled Tuesday that BlueCross BlueShield of Tennessee Inc.'s case accusing a Pfizer Inc. unit and Mutual Pharmaceutical Co. of colluding to block generic versions of the muscle...To view the full article, register now.
Already a subscriber? Click here to view full article